Ischemic colitis as a cause of severe hematochezia: A mini review

Usah Khrucharoen1,2,3,4, Dennis M Jensen1,2,3,4

  • 1CURE Hemostasis Research Unit and the UCLA Digestive Diseases Research Core Center (UCLA: DDRCC), Los Angeles, CA, USA.

Journal of Clinical and Experimental Gastroenterology
|September 12, 2022
PubMed

Insights

Ischemic colitis (IC) is a frequent cause of severe lower gastrointestinal bleeding in seniors. Most patients with severe hematochezia from IC can be treated non-surgically, but surgery indicates worse outcomes.

Area of Science:

  • Gastroenterology
  • Colorectal Surgery
  • Internal Medicine

Background:

  • Ischemic colitis (IC) is a significant cause of severe lower gastrointestinal bleeding (LGIB), particularly in the elderly population.
  • Limited literature exists on IC as a primary cause of severe LGIB, necessitating a comprehensive review.

Purpose of the Study:

  • To review the diagnosis, colonoscopic findings, medical treatment strategies, and clinical outcomes for patients presenting with severe hematochezia due to IC.
  • To evaluate the efficacy and safety of colonoscopic hemostasis and surgical interventions in managing IC-related severe bleeding.

Main Methods:

  • Literature review focusing on diagnosis, colonoscopic findings, and treatment modalities for ischemic colitis.
  • Analysis of outcomes based on treatment approach (medical vs. surgical) and patient setting (inpatient vs. outpatient).

Main Results:

  • The majority of severe hematochezia cases from IC are manageable with medical treatment.
  • Colonoscopic hemostasis using hemoclips is a safe and feasible option for focal ischemic ulcers with major hemorrhage stigmata.
  • Colon surgery is reserved for patients refractory to medical treatment, experiencing ongoing severe bleeding, clinical deterioration, or peritoneal signs, and is associated with higher morbidity.

Conclusions:

  • Medical management is effective for most patients with severe hematochezia from IC.
  • Colonoscopic interventions offer a viable alternative for managing active bleeding in focal ischemic ulcers.
  • Surgical intervention for IC is associated with poorer clinical outcomes compared to medical management, highlighting the importance of early and appropriate treatment strategies.

Related Concept Videos

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
298
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
526
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
229
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
355
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
122
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
293